128 related articles for article (PubMed ID: 3972502)
1. Lysis of herpes simplex virus (HSV) infected targets. IV. HSV-induced change in the effector population.
Hendricks RL; Sugar J
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):208-13. PubMed ID: 3972502
[TBL] [Abstract][Full Text] [Related]
2. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
Hendricks RL; Sugar J
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):201-7. PubMed ID: 2579040
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
4. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
5. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
Muñoz A; Carrasco L; Fresno M
J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
[TBL] [Abstract][Full Text] [Related]
7. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
[TBL] [Abstract][Full Text] [Related]
9. Lysis of herpes simplex virus-infected targets. II. Nature of the effector cells.
Hendricks RL; Sugar J
Cell Immunol; 1984 Feb; 83(2):262-70. PubMed ID: 6692480
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts.
Oh SH; Bandyopadhyay S; Miller DS; Starr SE
J Immunol; 1987 Oct; 139(8):2799-802. PubMed ID: 2821120
[TBL] [Abstract][Full Text] [Related]
11. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes.
Torpey DJ; Lindsley MD; Rinaldo CR
J Immunol; 1989 Feb; 142(4):1325-32. PubMed ID: 2464644
[TBL] [Abstract][Full Text] [Related]
12. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
13. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
[TBL] [Abstract][Full Text] [Related]
14. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
[TBL] [Abstract][Full Text] [Related]
15. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
Fitzgerald PA; Mendelsohn M; Lopez C
J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
[TBL] [Abstract][Full Text] [Related]
16. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
Paya CV; Schoon RA; Leibson PJ
J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
[TBL] [Abstract][Full Text] [Related]
17. Role of interferon in natural kill of HSV-1-infected fibroblasts.
Fitzgerald PA; von Wussow P; Lopez C
J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
Tamesis RR; Foster CS
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
[TBL] [Abstract][Full Text] [Related]
19. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
20. Defective NK cell activity following thermal injury.
Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]